GlobeNewswire 2025-11-06 Denali Therapeutics Announces Board and Executive Leadership Updates
GlobeNewswire 2025-11-06 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Essential U...
GlobeNewswire 2025-11-06 Genmab Announces Financial Results for the Nine Months of 2025
GlobeNewswire 2025-11-06 Novel Pipeline Activity Signals Hope in Systemic Sclerosis, as Rheumatologists Anticipate First Real...
GlobeNewswire 2025-11-06 Monte Rosa Therapeutics Announces Third Quarter 2025 Financial Results and Business Updates
GlobeNewswire 2025-11-06 Pharming Group reports third quarter 2025 financial results with significant growth in revenue, prof...
GlobeNewswire 2025-11-05 Royalty Pharma Reports Third Quarter 2025 Results
GlobeNewswire 2025-11-05 Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire 2025-11-04 Esperion Appoints Industry Veteran John Harlow as Chief Commercial Officer
GlobeNewswire 2025-11-04 New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM p...
GlobeNewswire 2025-11-03 The Heart-Body Connection: How Other Organ Systems Affect Heart Health
GlobeNewswire 2025-11-03 Pond Lehocky Giordano Welcomes Nationally Recognized Litigator Jeremy Abay to Lead New Haddonfield O...
GlobeNewswire 2025-11-03 Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (AS...
GlobeNewswire 2025-10-30 Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development
GlobeNewswire 2025-10-30 Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 2025-10-29 Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Pha...
GlobeNewswire 2025-10-29 Immutep Quarterly Activities Report Q1 FY26
GlobeNewswire 2025-10-28 RNA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Avidity Biosciences, Inc. is ...
TeleTrader 2025-10-28 Europe closes mixed ahead of ECB, Fed decisions
GlobeNewswire 2025-10-28 Novartis completes acquisition of Tourmaline Bio
GlobeNewswire 2025-10-28 Sevaro Health Named to the 2025 CB Insights’ List of the 50 Most Promising Digital Health Startups
GlobeNewswire 2025-10-28 Cingulate Presents Positive Phase 3 Results for CTx-1301 Demonstrating Statistically Significant Eff...
GlobeNewswire 2025-10-28 Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer
GlobeNewswire 2025-10-28 Amphista Therapeutics to showcase how its Targeted Glue™ technology is expanding the diversity of TP...
TeleTrader 2025-10-28 Europe mostly down at open amid data